November 06, 2024 04:55 (IST)
Glenmark launches Tavulus for COPD treatment in Spain
Mumbai/UNI: Pharma major Glenmark Pharma Monday announced the launch of a bioequivalent version of Tiotropium Bromide dry powder inhaler (DPI) under the brand name Tavulus in Spain for the treatment of chronic obstructive pulmonary disease (COPD).
Glenmark Pharma receives ANDA approval for Fingolimod Capsules, 0.5 mg
Mumbai/UNI: Glenmark Pharmaceuticals Inc, USA has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Fingolimod Capsules, 0.5 mg, the generic version of Gilenya Capsules, 0.5 mg, of Novartis Pharmaceuticals Corporation.
Latest Headlines
Glenmark launches Tavulus for COPD treatment in Spain Mon, Oct 11 2021